LCT 0.01
30 September 2022
Annual Report
Annual Report to shareholders for fiscal 2022, including some significant milestones for LCT in advancing the third clinical trial of NTCELL in Parkinson's disease.
30 September 2022
Appendix 4G and Corporate Governance Statement
Appendix 4G and Corporate Governance Statement for Living Cell Technologies.
30 September 2022
2022 Annual General Meeting and Proxy Form
2022 Annual General Meeting and Proxy Form for shareholders of Living Cell Technologies.
27 September 2022
New 2022 Annual General Meeting date
Living Cell Technologies advises its 2022 Annual General Meeting will now be held at 2pm AEDT on Thursday, 10 November 2022, rather than 31 October 2022 as previously announced.
19 September 2022
2022 Annual General Meeting date
Living Cell Technologies advises that in accordance with ASX Listing Rule 3.13.1, the 2022 Annual General Meeting of shareholders will be held on 31 October 2022 at 2.00pm.